Disulfide With Human Monoclonal Medi2070 .lambda.-chain
Disulfide With Human Monoclonal Medi2070 .lambda.-chain Uses, Dosage, Side Effects, Food Interaction and all others data.
Disulfide With Human Monoclonal Medi2070 .lambda.-chain is under investigation in clinical trial NCT03759288 (An Active and Placebo-controlled Study of Disulfide With Human Monoclonal Medi2070 .lambda.-chain in Participants With Moderately to Severely Active Crohn's Disease).
| Trade Name | Disulfide With Human Monoclonal Medi2070 .lambda.-chain |
| Generic | Brazikumab |
| Brazikumab Other Names | Brazikumab, Immunoglobulin g2, anti-(human interleukin 23) (human monoclonal medi2070 heavy chain), disulfide with human monoclonal medi2070 .lambda.-chain, dimer |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Disulfide With Human Monoclonal Medi2070 .lambda.-chain
